Výsledky vyhledávání

Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study

Autor: Sarah Khan, Michael Ho, Syed Karim, Aaruni Saxena, Sumbal Umar, Tahir Shafiq

Publikováno v: Lung Cancer. 156:S37-S38

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6fbfbbf30522bcd58cbcd7d7c7d9cadb
https://doi.org/10.1016/s0169-5002(21)00289-0

Zobrazit plný text záznamu

Real-world outcomes from the systemic use of CDK 4/6 inhibitors (CDKIs) in the management of ER positive (+) HER2 negative (-) metastatic breast cancer (mBC)

Autor: Srinivasan Madhusudan, Sumbal Umar, Maria Diossy, Karen Desouza, Anjana Anand, Emma Gore, Sachin Trivedi, Daniel Yeo, Sarah Khan

Publikováno v: Journal of Clinical Oncology. 39:e13031-e13031

e13031 Background: The use of CDKIs have transformed the management of ER+HER2- mBC. As the real-world data matures, this project describes patterns in response to systemic therapy that may inform treatment planning and prognostication. Methods: We a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f32880bf7260e7ea73ead6f10fe7ba7
https://doi.org/10.1200/jco.2021.39.15_suppl.e13031

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání